Dortmund, Germany

Safa Kutup Kurt

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Safa Kutup Kurt

Introduction

Safa Kutup Kurt is a notable inventor based in Dortmund, Germany. She has made significant strides in the field of virus inactivation technology. Her work is particularly relevant in today's world, where the need for effective virus control is paramount.

Latest Patents

Safa holds a patent for a "Device and method for continuous virus inactivation." This invention provides an apparatus and a process for continuous virus inactivation in a product stream. The apparatus comprises a tube or hose with an inlet and an outlet connected to a product flow line. The design includes a curved and/or helically coiled tube with multiple windings around a coil axis. It features changes in direction and bends in the coil axis, which alter the direction of action of the centrifugal force. The apparatus is characterized by a Dean number greater than 0 and a torsion parameter greater than 0. This innovative approach enhances the efficiency of virus inactivation processes.

Career Highlights

Safa is currently employed at Bayer Aktiengesellschaft, where she continues to develop her innovative ideas. Her work at Bayer has allowed her to contribute to advancements in health and safety technologies. With her expertise, she plays a crucial role in the company's research and development efforts.

Collaborations

Safa collaborates with talented colleagues, including Martin Lobedann and Stephan Klutz. These partnerships enhance her research and foster a collaborative environment for innovation.

Conclusion

Safa Kutup Kurt is a pioneering inventor whose work in virus inactivation technology is making a significant impact. Her contributions at Bayer Aktiengesellschaft and her innovative patent demonstrate her commitment to advancing health and safety solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…